Search results
Fact Check: Posts on Pfizer CEO calling COVID pandemic a rehearsal are misleading
Reuters· 1 day agoA 2023 quote from Pfizer CEO Albert Bourla describing the COVID-19 pandemic as a “rehearsal” has...
Pfizer (PFE), BioNTech's Updated COVID-19 Jab Gets CHMP Nod
Zacks via Yahoo Finance UK· 1 day agoPfizer (PFE) and BioNTech's Omicron JN.1-adapted COVID-19 vaccine gets the Committee for Medicinal...
US drug giant Pfizer beats GSK to UK government contract for 4.9m vaccine shots
CityAM via Yahoo Finance UK· 4 days agoPfizer has beaten GSK to win a contract to supply millions of doses of a new respiratory vaccine in...
COVID summer guide: How to navigate symptoms, variants and vaccines this season amid rising cases
Yahoo Life· 4 days agoWho should wait and who should get vaccinated now? The CDC advises that everyone age 5 and older...
Is Pfizer Inc. (PFE) the Best Healthcare Stock to Buy Under $50?
Insider Monkey via Yahoo Finance UK· 2 days agoWe recently compiled a list of the 10 Best Healthcare Stocks to Buy Under $50. In this article, we...
Did Seagen Acquisition Help Pfizer Inc. (PFE) Increase Revenue in Q1?
Insider Monkey via Yahoo Finance UK· 5 days agoWe recently compiled a list of the 10 Best Healthcare Stocks to Buy According to Hedge Funds. In...
The GSK share price just tumbled (again). Is this FTSE 100 stock now a bargain?
Fool.co.uk via Yahoo Finance UK· 1 day agoMore bad news from across the pond has hit the GSK share price. But does an attractive valuation and...
UK Government Snubs GSK in Favor of Pfizer’s Rival RSV Shot
Bloomberg· 5 days agoHave a confidential tip for our reporters? GSK Plc has lost out to Pfizer Inc. on a contract to...
Pfizer And Five Other Dividend-Yield Standouts
Forbes· 6 days ago“Would you kindly do a piece on high dividend stocks,” a reader asked recently. My favorite high-divided stock at the moment is Pfizer Inc. (PFE). In my...
Pfizer (PFE) Stock Sinks As Market Gains: Here's Why
Zacks via Yahoo Finance UK· 4 days agoPfizer (PFE) closed the latest trading day at $27.99, indicating a -1.3% change from the previous session's end. The stock fell short of the S&P 500,...